Disease Demographics for Diabetes Type 1 and Type 2, 2023Report

Disease Demographics for Diabetes Type 1 and Type 2, 2023

  • Published Date: Apr, 2023
  • Report ID: GVR-MT-100113
  • Format: Electronic (PDF)
  • Number of Pages: 30

Diabetes Type 1 & 2 - The Prevalence of the Disease and its Effects

The increase in the prevalence of diabetes globally has resulted in the growing demand for the adoption of diabetes devices and treatments, which in turn helps to generate income. For the past eight years, it has been the most important indicator that our internal team of analysts has tracked. Through our constant monitoring of the diabetes disease demographics, we have seen how this disease prevalence has been rising rapidly resulting in other associated disorders. To help understand and highlight diabetes disease prevalence, patient demographics, treatment options, and associated costs in various countries, we have designed this particular study, which would help researchers, manufacturers, distributors, and healthcare professionals with quick and effective decision-making.

A company's market entry is a significant operation that carries a lot of risk. This study could assist one in launching a new product in an established regional market or introducing an existing product into a new regional market. Research insights offer valuable and practical suggestions for potential future growth and opportunities as well as a comprehensive image of the market. With our knowledge of market research, we can offer suggestions for reducing risk and helping individuals make choices that will put them on a path to long-term growth. Key analytical insights on the following important business aspects are provided by our research team:

  • Diabetes demographics country wise

  • Diabetes-related expenditure per person

  • Customer buying behavior and decision-making process

  • Reimbursement scenario

Disease Demographics for Diabetes Type 1 and Type 2 Report Scope



Patient Demographics

  • Total Population
  • People with diabetes
  • People with undiagnosed diabetes
  • Deaths attributable to diabetes

Treatment Options

  • Type 1 Diabetes
    • Insulin
    • Diet
    • Blood glucose monitoring
  • Type 2 Diabetes
    • Oral Medications
    • Diet
    • Exercise
    • Blood glucose monitoring
    • Insulin

Treatment Cost Per Patient

  • Total diabetes-related health expenditure, USD Million
  • Diabetes-related health expenditure per person, USD

Quality of Life

  • Disability-adjusted life years (DALYs)

Comorbidity Analysis

  • Diabetic foot ulcer
  • Cardiovascular disease (CVD)
  • Diabetic retinopathy
  • Diabetic neuropathy
  • Diabetic nephropathy

Reimbursement Differences

  • Coverage for Medicare and Medicaid
    • Type 1 Diabetes
    • Type 2 Diabetes


  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait


Diabetes is a rapidly growing disease, which has been affecting a large population around the world, owing to an increase in unhealthy lifestyles and other associated risk factors. It has massive effects on civilization, people, societies, and nations. About 536.6 million people were living with diabetes in 2021, which is expected to increase to 783.7 million by 2045. Lifestyle factors such as eating behavior and physical activity as well as obesity play a major role in the prevention & treatment of diabetes. Patient satisfaction is considered an important measure to evaluate the quality of health services and can predict both compliance & utilization, which are associated with the continuity of care; it is widely known that identifying patient requests, needs, and judgments on healthcare received is the first step of a patient-centered approach. 

An in-depth analysis of the disease demographics shall be provided for each country and shall include pointers such as:

Diabetes Disease Demographics for Saudi Arabia





Diabetes population (20-79 years) in 1,000s




Age-adjusted comparative prevalence of diabetes




Cost per person with diabetes (USD)




Diabetes-related deaths




Proportion of undiagnosed diabetes




Total adult population (20-79 y), in 1,000s




gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.